Skip to main content

Table 3 Glucose-related biomarkers at baseline and after the 6-week intervention

From: Antihyperglycemic effect of short-term arginyl-fructose supplementation in subjects with prediabetes and newly diagnosed type 2 diabetes: randomized, double-blinded, placebo-controlled trial

 

Placebo (n = 24)

Test (n = 25)

Hemoglobin A1c (%)a

  

 0 week

6.4 ± 0.16

6.4 ± 0.14

 6 week

6.2 ± 0.14***

6.1 ± 0.13**

Insulin (uU/mL)a

  

 0 minutes

  

  0 week

9.5 ± 0.77

11.1 ± 1.03

  6 week

9.2 ± 0.68

12.4 ± 2.49

 30 minutes

  

  0 week

30.5 ± 3.93

43.7 ± 8.26

  6 week

21.3 ± 3.03*

41.3 ± 8.60

 60 minutes

  

  0 week

44.5 ± 6.35

58.5 ± 9.34

  6 week

34.9 ± 5.06*

46.3 ± 8.21*

 120 minutes

  

  0 week

46.7 ± 7.65

56.1 ± 10.58

  6 week

36.3 ± 6.49

42.1 ± 7.46

Insulin AUC (uU/mL per hour)a

  

 0 week

74.3 ± 8.66

96.6 ± 13.98

 6 week

57.3 ± 7.72**

79.5 ± 11.74*

C-peptide (ng/mL)a

  

 0 minutes

  

  0 week

2.1 ± 0.16

2.5 ± 0.18

  6 week

2.1 ± 0.15

2.7 ± 0.33

 30 minutes

  

  0 week

5.1 ± 0.38

6.0 ± 0.60

  6 week

4.4 ± 0.39*

5.9 ± 0.71

 60 minutes

  

  0 week

7.5 ± 0.49

8.6 ± 0.75

  6 week

6.8 ± 0.47*

8.0 ± 0.68

 120 minutes

  

  0 week

9.4 ± 0.67

9.1 ± 0.69

  6 week

9.2 ± 0.65

8.4 ± 0.64

C-peptide AUC (ng/mL)a

  

 0 week

13.4 ± 0.79

14.6 ± 1.10

 6 week

12.4 ± 0.83*

13.8 ± 1.01

  1. Data are shown as mean ± SEM
  2. p < 0.1, *p < 0.05, **p < 0.01, ***p < 0.001 compared to 0 week, tested by paired t-test
  3. aAnalyzed after log transformation
  4. AUC Area under the curve